Comment
. 2004 Jan 15;38(2):304-5; author reply 306-7.
doi: 10.1086/380844.
Amphotericin B: is a lipid-formulation gold standard feasible?
- PMID: 14699470
- DOI: 10.1086/380844
Item in Clipboard
Comment
Amphotericin B: is a lipid-formulation gold standard feasible?
Clin Infect Dis.
.
No abstract available
Comment on
-
Amphotericin B: time for a new "gold standard".Clin Infect Dis. 2003 Aug 1;37(3):415-25. doi: 10.1086/376634. Epub 2003 Jul 22. Clin Infect Dis. 2003. PMID: 12884167
Similar articles
-
Lipid amphotericin B formulations as comparators in clinical trials.Clin Infect Dis. 2004 Jan 15;38(2):305-6; author reply 306-7. doi: 10.1086/381269. Clin Infect Dis. 2004. PMID: 14699471 No abstract available.
-
Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?Clin Infect Dis. 2004 Jan 15;38(2):303-4; author reply 306-7. doi: 10.1086/380843. Clin Infect Dis. 2004. PMID: 14699468 No abstract available.
-
Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.Clin Infect Dis. 2002 Oct 1;35(7):896-7; author reply 897-8. doi: 10.1086/342564. Clin Infect Dis. 2002. PMID: 12228830 No abstract available.
-
Lipid formulations of amphotericin B. Less toxicity but at what economic cost?Drug Saf. 1995 Oct;13(4):207-18. doi: 10.2165/00002018-199513040-00001. Drug Saf. 1995. PMID: 8573294 Review. No abstract available.
-
[Liposomal amphotericin B: a unique pharmacokinetic profile. An unfinished story].Rev Esp Quimioter. 2012 Mar;25(1):17-24. Rev Esp Quimioter. 2012. PMID: 22488537 Review. Spanish.
Cited by
-
Evaluating real-life clinical and economical burden of amphotericin-B deoxycholate adverse reactions.Int J Clin Pharm. 2012 Aug;34(4):611-7. doi: 10.1007/s11096-012-9654-y. Epub 2012 Jun 7. Int J Clin Pharm. 2012. PMID: 22674178
-
Novel perspectives on mucormycosis: pathophysiology, presentation, and management.Clin Microbiol Rev. 2005 Jul;18(3):556-69. doi: 10.1128/CMR.18.3.556-569.2005. Clin Microbiol Rev. 2005. PMID: 16020690 Free PMC article. Review.
-
Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections.Pharmaceutics. 2023 Nov 8;15(11):2601. doi: 10.3390/pharmaceutics15112601. Pharmaceutics. 2023. PMID: 38004579 Free PMC article.
-
Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies.Support Care Cancer. 2005 Dec;13(12):987-92. doi: 10.1007/s00520-005-0783-x. Epub 2005 Mar 9. Support Care Cancer. 2005. PMID: 15756584
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
